{"name":"California Retina Consultants","slug":"california-retina-consultants","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQRzd0QjF1WURiQ3AxR2Rxb2hmV1hzZ0RKUnMySlg0emtleXhmTlRRVVNySVRnUERDNUgtQWw2ZzZRTlVkTjQwMGZDUEh0UnUwRGhBWFRpbUY3WnhXM3JxRDBVTEE5Q3hvV2xUOU9Rd2JJY1JULTlWUnRPejR5MEVweDBudWlSSVJWRjlqTmNWajl5LXJaMEdQT0pJbUl5S2k2YmF1Mm93SFVsOHFtenAxaTg3RVZHMmF0UXg3Z2FMSjdJandVcHNpV3FMenNSbHc?oc=5","date":"2026-03-06","type":"pipeline","source":"Ophthalmology Times","summary":"Pegcetacoplan Saves 1.5 Years of GA Lesion Progression in GALE Extension, With Dilsher Dhoot, MD - Ophthalmology Times","headline":"Pegcetacoplan Saves 1.5 Years of GA Lesion Progression in GALE Extension, With Dilsher Dhoot, MD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNSHREZDlGc3I2dkRnaXVGdkdhdnFfX1ZsY1dYMmtENkI3VVp1dmxFbHd0Y0xaMFFxZTBlSXF4WTNJMFlIaUJxcTJLSWgxQTZpeTRvYlp1NHRUYXE2MjgtVHBmamM5LXJlTWF5RGQyb2RrSnZTNjB0WDg1bElQV3FYVDNhUUlMRGtBR0NqYkJxU0JjNXhlS1VLYXZMNVhpLUdwS1JGWU50SjY1bGlER29GM0lZSQ?oc=5","date":"2026-02-13","type":"deal","source":"Fierce Pharma","summary":"Astellas casts retina specialists as 'Partners in Protection' in Izervay HCP campaign - Fierce Pharma","headline":"Astellas casts retina specialists as 'Partners in Protection' in Izervay HCP campaign","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPaEh6NnBlTFV1WlRNZTk0NVJlQ29oYUdBYXZEQlRVa3JKcDd6Q0hqQmtadDR3NGFzZXdwNGctZHdfM1pILVlqMGt6M0RfYlp5bnNSTE1IOW9GVWQyblJXUFBmTzFlWEFNOUJ0SFh3cXhyVVJucGJPdU5Halh4RTZtUHdJdU05MUdlWHg4TjBIVG9mSlcyajNiekpRR2xkcVdCWXZFSURadG95eGhlQVNGR09aVTNua3N1VnFN?oc=5","date":"2026-01-27","type":"pipeline","source":"Investing.com","summary":"Kiora Pharmaceuticals adds retina specialist to advisory board - Investing.com","headline":"Kiora Pharmaceuticals adds retina specialist to advisory board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTGJjQ3NVOWhWQloyTVZRQWd3QVlGSmlBTzJuaFdSeW5TeVVNczRDMW54NnlHNmV4ajNyc2pCREhaN09LRGFBQzdPNGNROUgtenh6dFVyNjVCQ2IxYXFOOTBSWjZ3eEhDR002R2JaMlNrV0ZCT05zQXVjN1RUMmtydVRGbXFKemhBTW02OW0tWDdCZmJJZnc5WlR5NjJsSWlQYl9kbElkUUdEVmhIc1V4bVJNSXc4WEN5SEV1bU1xZE8?oc=5","date":"2026-01-27","type":"pipeline","source":"Stock Titan","summary":"Why a leading retinal surgeon is backing new non-steroid eye drugs - Stock Titan","headline":"Why a leading retinal surgeon is backing new non-steroid eye drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOOXI2cVlhVDJyU2dxUFBleVJLSk1RWVJJc3pCbUJ0bDVTS2NzQVBMMURkbVF0a1VOTzN3VGt4bEk5WmkxVENwYVp6NnZYR3oxNGpMR1FIUmhPNks4ek4tNnd1ZDJKclBtWFYxQzVoeWZGRlVCX2tIZ0xqb0pnR2Z5LWdFZ2U5RzR6NjdaMnM3dzdWWUFNVGROa28xcXVqUQ?oc=5","date":"2025-12-04","type":"trial","source":"Yahoo Finance","summary":"Alkeus Pharmaceuticals Announces Gildeuretinol Data Will Be Presented During the 13th International FLORetina ICOOR Congress December 4–7 in Florence, Italy - Yahoo Finance","headline":"Alkeus Pharmaceuticals Announces Gildeuretinol Data Will Be Presented During the 13th International FLORetina ICOOR Cong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQcVE0cUdKUE5ZaFBjQ3lsVzh1TXJsSmtPVjhvcWlYVDF6LW83RWNDMHJqR2ZCaTk3SUxNck5jV2xoMFNKM1Zqd2ZVSU1jT1ZySXR3ZFFxNlpXRnFuSFZtZnlHdlA1MUFLTHc1Um9zYVFqV053aGctYnMxby1iU2dtakNqemF2bWQ0N1U3QnFVclJuM1V4RW1acS1sU3kyb2wzTGlUUFRHTGE2RTJiWC1FRjN0aEZqekdpS1h6U2phVG5iX2x5dTRscFA1UHhXRkNLa0pvaFlQN3Q4dkZPemUyQUlrazRUaHZ6dkZnTmRvUG85RFU5WFktbGdxbDhiQQ?oc=5","date":"2025-11-13","type":"trial","source":"BioSpace","summary":"Apellis Announces 5-Year GALE Data Showing SYFOVRE® (pegcetacoplan injection) Delayed Progression of Geographic Atrophy by ~1.5 Years - BioSpace","headline":"Apellis Announces 5-Year GALE Data Showing SYFOVRE® (pegcetacoplan injection) Delayed Progression of Geographic Atrophy ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdVNUQWlKbExGT0ZHTVgtbExHYmw1dGtSdHU1cjN2Ymw5ME1QcnNRTkFWeFZSaEl4VkdnV3NKVlE0bFVhRVEwVE9fenZoQmJJbEZPUXlLb1hBTnhjVWlJTHZKa18wUGE3T3VNUnh5UUpfd3p4Y2NkZ2huajVySWFPX3lsSzZJV1RwelJqekIxRE5FSEpSb0tmM3dORmRxQjc3aXBhQmk0S0U?oc=5","date":"2025-06-03","type":"pipeline","source":"Healio","summary":"When should patients be referred to retina specialists? - Healio","headline":"When should patients be referred to retina specialists?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPVlVXVW5rMnZkM2RqQkZUdDdEeFF0UTd4Sl8xSmY5MEVJUXdpN2dtdUZNbWJkR0h1dF9pLU50aEdRTzN5WE8wdXBrdnlldFZUeDM2eEdWRVRFazhIWG9IYWVyUE1mTzlXcmZjN3BmTS1RSHNXaTN5TTduX2pHNzh2dktUX2VNc1BGZnhzTW8wUlZPbUxBNVMwYVl1emVpYktlV1JXeWRtU3RqSTQ?oc=5","date":"2025-05-10","type":"trial","source":"Ophthalmology Times","summary":"Q&A: Dilsher S. Dhoot, MD, on the HELIOS trial for diabetic retinopathy - Ophthalmology Times","headline":"Q&A: Dilsher S. Dhoot, MD, on the HELIOS trial for diabetic retinopathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQSXZrV3lWX1R4RGFTeVM4MjM0RnBQVmtpSW5NWm13cWh1OGdveWdBeGh1TnBUWG9jX2tpcXhDU2prUE5MSkpRTnBlOWJlOWcwSGNaUWpyQ212b3Y0OGV2T1hTamZzdWg1R2ZFUHR3UU1Wb3c4MHJiMHpYVml1SnV5RzNZZjl0eVpia3VFRkxHdkk0dw?oc=5","date":"2024-11-08","type":"deal","source":"Fierce Healthcare","summary":"Cencora to buy Retina Consultants of America in $4.6B deal to expand specialty services - Fierce Healthcare","headline":"Cencora to buy Retina Consultants of America in $4.6B deal to expand specialty services","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFBvd3VWaTdlNURibHREVDVYQ1d4M285dFVOSnItdE9vdVNWT2t5Yzk1VUMxN3l2REpwS0NCYnV2Rzg5V2Nmc00zb0xUZ2MxRjJTYTRlbUZR?oc=5","date":"2023-08-08","type":"pipeline","source":"Medscape","summary":"Long-Term Outcomes of Pegcetacoplan for GA Show Promise - Medscape","headline":"Long-Term Outcomes of Pegcetacoplan for GA Show Promise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNUTdBclE5ZWU2Vnl5dkx1X09yVXJlUVYtVV9MMWRadFo0ZG9GVGZRSXk5OE5kellqclRkY1RtdXVacmRVdTcwYlVLTkJURzBfdW10OEZLa0p5Q0d0UjdEQjdDN2QxWG1sZmNMb1l0TDRUWlhKalVmTGJCR1BlQlZ6azBJREM4NTdMRXd1aEtqclc4V0tISFViZVpHaGM0MXUtdkdxbnljMUF6Yk95N0JCUzV1MG1IbGN4bWRxMjJ5TWpWajU3UlM2LWpwTDA?oc=5","date":"2023-08-02","type":"pipeline","source":"Optometry Times","summary":"Pegcetacoplan shows increasing beneficial effects after 30 months of continuous treatment for GA - Optometry Times","headline":"Pegcetacoplan shows increasing beneficial effects after 30 months of continuous treatment for GA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE52aFN6OWhXaDVkcFViUGNqZzFKYnV4cjZGRzNfNjNLaXQ2RUFjTlRpOHRXSU5wNjRMdjdBeEpaUTE5YXk4MllOWE1aRDVldldfdHNLY2RXbHZwOG43Q3RV?oc=5","date":"2023-05-12","type":"trial","source":"nature.com","summary":"The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results - nature.com","headline":"The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 m","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}